AzurRx BioPharma Inc(AZRX)stock report

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements AzurRx BioPharma, Inc. is a clinical development-stage biopharmaceutical company. The Company is engaged in the research and development of…

Continue Reading AzurRx BioPharma Inc(AZRX)stock report